Key result
Subcutaneous and transvenous ICDs yield comparable 4% short-term complication rates and implantation durations.
Why the study?
How do peri-procedural routines, implantation techniques, and short-term complications compare between S-ICD and TV-ICD implantations?
Observational (n=429)
Yes
How do peri-procedural routines, implantation techniques, and short-term complications compare between S-ICD and TV-ICD implantations?
Despite differences in peri-procedural routines and settings, S-ICD and TV-ICD implantations have comparable duration and short-term complication rates, supporting the routine clinical use of both devices.
Answers are grounded in this paper and cite their sources.
May inform individualized S-ICD or TV-ICD selection; extends observational data but leaves randomized confirmation open.
The aim of this European Heart Rhythm Association (EHRA) prospective snapshot survey is to assess peri-procedural practices, implantation techniques, and short-term procedure-related complications associated with implantation of subcutaneous implantable cardioverter-defibrillator (S-ICD) or transvenous implantable cardioverter-defibrillator (TV-ICD), across tertiary European electrophysiology centres. An internet-based electronic questionnaire concerning implantation settings, peri-procedural routines, techniques, personnel, complications, and patient outcomes was sent to the centres routinely implanting both TV-ICDs and S-ICDs. The centres were requested to prospectively include consecutive patients implanted with either TV-ICD or S-ICD during the 8-week enrolment period. Overall, 20 centres from 6 countries enrolled 429 consecutive patients. Subcutaneous implantable cardioverter-defibrillators (20%) compared with TV-ICD were implanted mainly under general anaesthesia (72% vs. 14%), in the surgical operation room settings (69% vs. 43%), with more frequent prophylactic antibiotic administration (82% vs. 91%), and post-implant defibrillation testing (85% vs. 7%, all P < 0.05). Feasibility (implantation duration of 45 min) and short-term complication rates (4%) were comparable for S-ICDs and TV-ICDs, but the spectrum of complications varied, despite different baseline characteristics of patients undergoing the S-ICD vs. TV-ICD implantation. This EHRA snapshot survey provides important insights into the implantable cardioverter-defibrillator implantation routines and patient outcomes. Our study showed differences between the S-ICD and TV-ICD implantation routines with respect to implantation settings, peri-procedural management, and pre-defined procedural endpoints. However, the comparable duration of S-ICD or TV-ICD implantation and similar rates of peri-procedural complications indicate that both devices can be routinely used in clinical practice.
No takes yet. Share an insight, caveat, or question.
Lenarczyk et al. (2018) conducted an observational in Patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators (n=429). Subcutaneous implantable cardioverter-defibrillator (S-ICD) vs. Transvenous implantable cardioverter-defibrillator (TV-ICD) was evaluated on Short-term procedure-related complications. Subcutaneous and transvenous implantable cardioverter-defibrillators showed comparable short-term complication rates and implantation durations, despite differing peri-procedural routines.
Synapse has enriched 10 related papers. Consider them for comparative context: